The risk of taking dupilumab for the treatment of atopic dermatitis during the COVID-19 pandemic is assessed.
Learn more at the Journal of the American Academy of Dermatology.
The risk of taking dupilumab for the treatment of atopic dermatitis during the COVID-19 pandemic is assessed.
Learn more at the Journal of the American Academy of Dermatology.